Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Beijing Luzhu Biotechnology Co., Ltd. Class H ( (HK:2480) ) has shared an announcement.
Beijing Luzhu Biotechnology Co., Ltd. has announced its 2025 Annual General Meeting to be held on June 12, 2025, where several key resolutions will be considered. These include the approval of the 2024 annual report, work reports from various boards, profit distribution plan, re-appointment of auditors, and election of board members and supervisors. This meeting is crucial for the company’s governance and strategic direction, impacting its operational and financial planning for the upcoming year.
More about Beijing Luzhu Biotechnology Co., Ltd. Class H
Beijing Luzhu Biotechnology Co., Ltd. is a joint stock company incorporated in China, operating within the biotechnology industry. The company focuses on developing and providing biotechnological products and services, catering to various market needs in the region.
Average Trading Volume: 124,526
Technical Sentiment Signal: Strong Sell
For detailed information about 2480 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue